Skip to main content
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience 3/2015

01.04.2015 | Editorial

Psychiatrists’ self-stigma, the DGPPN guideline for psychosocial interventions, and contemporary treatment strategies

verfasst von: Daniela Reich-Erkelenz, Andrea Schmitt, Peter Falkai

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Excerpt

Gaebel et al. [1] summarize the results of a survey conducted by the WPA task force on destigmatization, which assessed the extent to which the stigma of mental illness affects psychiatrists compared to general practitioners in 12 countries. The questionnaire presented to 1893 psychiatrists and 1238 general practitioners comprised perceived stigma, self-stigma (stereotype agreement), attitudes toward the other profession and experienced discrimination. Compared to general practitioners, psychiatrists reported significantly higher stigma and discrimination experiences. Additionally, perceived stigma in psychiatrists correlated best with discrimination experiences and self-stigma, whereas in general practitioners with self-stigma alone. Moreover, about 17 % of, by the majority, younger psychiatrists regarded stigma as a serious problem of their profession. Thus, existing antistigma interventions for mental health professionals and students need to be enhanced to raise awareness of own stigmatizing attitudes and to improve professional-related self-assertiveness. …
Literatur
1.
Zurück zum Zitat Gaebel W, Zäske H, Zielasek J, Cleveland H-R, Samjeske K, Stuart H, Arboleda-Florez J, Akiyama T, Baumann AE, Gureje O, Jorge M, Kastrup MR, Suzuki Y, Tasman A, Fidalgo TM, Jarema M, Johnson SB, Kola L, Krupchanka D, Larach V, Matthews L, Mellsop G, Ndetei DM, Okasha TA, Padalko E, Spurgeoun JA, Tyszkowska M, Sartorius N (2014) Stigmatization of psychiatrists and general practitioners: results of an international survey. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-014-0530-8 Gaebel W, Zäske H, Zielasek J, Cleveland H-R, Samjeske K, Stuart H, Arboleda-Florez J, Akiyama T, Baumann AE, Gureje O, Jorge M, Kastrup MR, Suzuki Y, Tasman A, Fidalgo TM, Jarema M, Johnson SB, Kola L, Krupchanka D, Larach V, Matthews L, Mellsop G, Ndetei DM, Okasha TA, Padalko E, Spurgeoun JA, Tyszkowska M, Sartorius N (2014) Stigmatization of psychiatrists and general practitioners: results of an international survey. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-014-0530-8
2.
Zurück zum Zitat Gühne U, Weinmann S, Arnold K, Becker T, Riedel-Heller SG (2014) S3 guideline on psychosocial therapies in severe mental illness: evidence and recommendations. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-014-0558-9 PubMed Gühne U, Weinmann S, Arnold K, Becker T, Riedel-Heller SG (2014) S3 guideline on psychosocial therapies in severe mental illness: evidence and recommendations. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-014-0558-9 PubMed
3.
Zurück zum Zitat Holl AK, Grohmann R, Letmaier M, Painold A, Mörkl S, Toto S, Kasper S (2014) Pharmacotherapy of anxiety disorders in German-speaking countries: current status and changes between 1994 and 2011. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-014-0523-7 PubMed Holl AK, Grohmann R, Letmaier M, Painold A, Mörkl S, Toto S, Kasper S (2014) Pharmacotherapy of anxiety disorders in German-speaking countries: current status and changes between 1994 and 2011. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-014-0523-7 PubMed
4.
Zurück zum Zitat Lay B, Blank C, Lengler S, Drack T, Bleiker M, Rössler W (2014) Preventing compulsory admission to psychiatric inpatient care using psycho-education and monitoring: feasibility and outcomes after 12 months. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-014-0553-1 Lay B, Blank C, Lengler S, Drack T, Bleiker M, Rössler W (2014) Preventing compulsory admission to psychiatric inpatient care using psycho-education and monitoring: feasibility and outcomes after 12 months. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-014-0553-1
5.
Zurück zum Zitat Tükel R, Aydın K, Ertekin E, Özyıldırım S, Barburoğlu M (2014) 1H-magnetic resonance spectroscopy in obsessive–compulsive disorder: effects of 12 weeks of sertraline treatment on brain metabolites. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-014-0545-1 PubMed Tükel R, Aydın K, Ertekin E, Özyıldırım S, Barburoğlu M (2014) 1H-magnetic resonance spectroscopy in obsessive–compulsive disorder: effects of 12 weeks of sertraline treatment on brain metabolites. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-014-0545-1 PubMed
6.
Zurück zum Zitat Bumb J, Suna S, Aksay C, Kranaster L, Geisel O, Gass P, Hellweg R, Sartorius A (2014) Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-014-0543-3 Bumb J, Suna S, Aksay C, Kranaster L, Geisel O, Gass P, Hellweg R, Sartorius A (2014) Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-014-0543-3
7.
Zurück zum Zitat Antel J, Albayrak Ö, Heusch G, Banaschewski T, Hebebrand J (2014) Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)? Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-014-0522-8 PubMed Antel J, Albayrak Ö, Heusch G, Banaschewski T, Hebebrand J (2014) Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)? Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-014-0522-8 PubMed
8.
9.
Zurück zum Zitat Chou K-J, Chen H-K, Hung C-H, Chen T-T, Chen C-M, Bo-Jian W (2014) Readiness to quit as a predictor for outcomes of smoking-reduction programme with transdermal nicotine patch or bupropion in a sample of 308 patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-014-0515-7 Chou K-J, Chen H-K, Hung C-H, Chen T-T, Chen C-M, Bo-Jian W (2014) Readiness to quit as a predictor for outcomes of smoking-reduction programme with transdermal nicotine patch or bupropion in a sample of 308 patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-014-0515-7
Metadaten
Titel
Psychiatrists’ self-stigma, the DGPPN guideline for psychosocial interventions, and contemporary treatment strategies
verfasst von
Daniela Reich-Erkelenz
Andrea Schmitt
Peter Falkai
Publikationsdatum
01.04.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 3/2015
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-015-0586-0

Weitere Artikel der Ausgabe 3/2015

European Archives of Psychiatry and Clinical Neuroscience 3/2015 Zur Ausgabe

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.